期刊文献+

雌激素受体、胰岛素样生长因子-1受体在不同大小子宫肌瘤中的表达 被引量:5

Expression and relation of ER,IGF-IR in the different size uterine leiomyoma
全文增补中
导出
摘要 目的探讨雌激素受体(ER)、胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子-1受体(IGF-1R)与子宫肌瘤生长的关系。方法选取40例因子宫肌瘤行全子宫切除术的标本,取肌瘤组织和正常肌层组织制成石蜡切片,采用免疫组化SABC法测定ER、IGF-1、IGF-1R的蛋白表达。结果子宫肌瘤组织中ER、IGF-1R表达阳性率分别为67.5%及65.0%,高于宫壁组织的30.0%及20.0%(P<0.05),子宫肌瘤最大直径>5 cm组ER、IGF-1R阳性表达率均为30.0%,与≤5 cm组的80.0%及76.6%比较,差异有统计学意义(P<0.05)。结论ER、IGF-1R在子宫肌瘤发生、发展早期及中期起作用,而当子宫肌瘤生长到一定程度后,ER、IGF-1R对肿瘤的生长和增生调控能力逐渐缺失,ER与IGF-1R机制所起作用减弱,而促进子宫肌瘤进一步生长的原因可能与其他途径有关。 Objective To investigate the relationship between uterine leiomyoma and estrogen re- ceptor or insulin-like growth factor typeI or insulin-like growth factor typeⅠreceptor.Methods The ex- pressions of estrogen receptor,insulin-like growth factor typeⅠand insulin-like growth factor typeⅠreceptor were detected by immunohistoehemistry SABC.Results Expressions of ER and IGF-1R in uterine leiomy- oma were significantly higher than those in myomertrium(P<0.05).There were statistical significantly differ- ent between the group of diameter to be more than 5 cm and lower than 5 cm in the expressions of ER and IGF-1R of uterine leiomyoma.Conclusion ER and IGF-1R come into effect in the early and mid period of the uterine neoplasms' development.While the uterine neoplasms grow for a certain degree,the ability of the ER and IGF-1R that make the neoplasms grow,regulate and multiply gradualy disappears.The funtion of mechanism of ER and IGF-1R in weakened.However the reason to promote the Uterine neoplasms grow any longer possibly relates to other gateways.
出处 《肿瘤研究与临床》 CAS 2007年第3期177-178,182,共3页 Cancer Research and Clinic
关键词 子宫肿瘤 平滑肌瘤 雌激素 受体 胰岛素样因子-1 Uterine neoplasms Leiomyoma Estrogen,Receptor Insulin-like growth facter typeⅠ
  • 相关文献

参考文献7

  • 1焦园园,叶棋浓,黄翠芬.细胞膜雌激素受体研究进展[J].肿瘤研究与临床,2004,16(2):128-130. 被引量:3
  • 2Dixon D,,He H,Haseman JK.Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Emiron Health Perspect . 2000
  • 3Navarro M,,Baserg R.Limited redundancy ofsurvivals from the typeI insulin like growth factor receptor. The Journal of Endocrinology . 2001
  • 4Tmey C,Meghan B,Shinako A,et al.Delayed activation of in- sulin-like growth factor-1 recepor/Src/Mapk/kgr-1 signaling regu- lates elusterin expression a pro-survival factor. Biological Chemistry . 2005
  • 5Maruo T,MatsuoH,Shimomura Y,et al.E ffects of progesterone on growth factor expression in human uterine leiomyoma. Steroids . 2003
  • 6Tzukerman MT,Esty A,Santiso-Mere D,etal.Human estrogen receptor transactivational capacity is determined by both cellular and promoter context an mediated by two functionallydistinct in tramolecula regions. Journal of Molecular Endocrinology . 1994
  • 7Jones JI,Clemmons DR.Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews . 1995

二级参考文献25

  • 1Chambliss K L, Yuhanna I S, Mineo C, et al. Estrogen receptor a and endothelial nitric oxide synthese are organized into a functional signaling module in caveolae [J].Circ Res, 2000, 87: e44-e52.
  • 2Cheng C C, Shapiro D J. Activation of the p38 mitogen-actived protein kinase pathway by estrogen or by 4- hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis [J]. J Bio chem, 2000,275: 479-486.
  • 3Morey A K, Razandi M, Pedram A, et al.Estrogen and progesterone inhibit the stimulated preduction of endothelin-1:differential positive and negative regulatory mechanisms [J]. Biochem J, 1998, 330(3): 1097-1105.
  • 4Razandi M, Pedram A, Levin E R. Plasma membnme estrogen receptors signal to anti-apoptosis in breast cancer [J]. Mol Endocrinol, 2000, 14:1434 -1447.
  • 5Kousteni S, Be]lido T, Plotkin L I, et al.Nongeno-tropic, sex-nonspecitic signaling through the estrognn or androgen receptors:dissociation from transcriptional activity[J]. Cell, 2001,104: 719-730.
  • 6Joel P B, Smith J, Sturgin T W, et al.pp90rskl regulates estrogen receptor-mediated transcription through phosphorylation of Ser- 167 [J]. Mol Cell Bio], 1998,18:1978 -1984.
  • 7Razandi M, Pedram A, Levin E R. Plasma membrane estrogen receptors signal to anti-apoptosis in breast cancer [J]. Mol Endocrianl, 2000,14:1434 - 1 447.
  • 8Simoncini T, Hafezi-Moghadam A, Brazil D P, et al. Interaction of cestrogen receptor with the regulatory subunit of phosphatidylinositol-3- OH kinase [J]. Nature, 2000,407: 538 -541.
  • 9Razandi M, Pedram A, kevin E R. Estrogen signals to preservation of endothelial cell form and function [J]. J Biol Chem,2000,275(49):38540 -38546.
  • 10Levin E R. Cellular functions of the plasma membrane estrogen receptor [J]. Trends Endocrinol Metab, 1999,10:374-376.

共引文献2

同被引文献101

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部